Melanotan 1 (also known as Afamelanotide or [Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2]) is a synthetic peptide analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). In laboratory settings, researchers evaluate Melanotan 1 to investigate melanocortin receptor signaling, cellular pigmentation pathways, and photoprotective mechanisms in preclinical cell and animal models.
Melanotan 1 (also known as Afamelanotide or [Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2]) is a synthetic peptide analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). In laboratory settings, researchers evaluate Melanotan 1 to investigate melanocortin receptor signaling, cellular pigmentation pathways, and photoprotective mechanisms in preclinical cell and animal models.
Melanotan 1 is a synthetic tridecapeptide designed as a structural analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). In molecular biology and dermatological research, scientists investigate what Melanotan 1 is used for across various model systems. The primary focus of inquiry centers on its high affinity for the melanocortin-1 receptor (MC1R), a G protein-coupled receptor expressed predominantly on cutaneous melanocytes.
Unlike native α-MSH, which exhibits a short biological half-life due to rapid enzymatic degradation by serum proteases, Melanotan 1 incorporates specific amino acid substitutions—notably Norleucine at position 4 and D-Phenylalanine at position 7. These chemical modifications significantly enhance metabolic stability and receptor binding kinetics. Researchers utilizing high-purity compounds like Melanotan 1 10mg in laboratory experiments examine these modified structural dynamics to understand long-term intracellular signal transduction without rapid ligand breakdown.
A primary objective in melanocortin research is mapping ligand-receptor binding profiles across the five known melanocortin receptor subtypes (MC1R through MC5R). Preclinical binding assays indicate that Melanotan 1 acts as a potent non-selective agonist with particularly high affinity for MC1R, while maintaining variable activity at MC3R, MC4R, and MC5R.
In vitro competitive binding studies demonstrate that when Melanotan 1 binds to MC1R on the surface of melanocytes, it activates heterotrimeric G proteins, triggering adenylyl cyclase activity. This elevation in intracellular cyclic adenosine monophosphate (cAMP) downstream activates protein kinase A (PKA). PKA subsequently phosphorylates the cAMP response element-binding protein (CREB), promoting the transcription of microphthalmia-associated transcription factor (MITF). Researchers measure these sequential biochemical events to chart the exact transcriptomic cascades governing enzymatic melanogenesis.
In cell culture environments, investigators utilize primary human melanocytes and immortalized cell lines to evaluate the direct cellular consequences of MC1R stimulation by Melanotan 1. Key endpoints measured in vitro include the transcription and enzymatic activity of tyrosinase, tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase (DCT/TYRP2).
Furthermore, co-culture models of melanocytes and keratinocytes allow researchers to explore cellular crosstalk following peptide exposure. In vitro data indicate that stimulation of MC1R by synthetic melanocortin analogs influences melanosome synthesis, maturation, and dendritic transfer to adjacent keratinocytes. These cell-based assays provide critical qualitative and quantitative data regarding how melanin density increases at the cellular level under controlled laboratory conditions. For related assays across diverse peptide classes, researchers frequently consult the comprehensive catalog of research peptides.
Extending findings beyond isolated cell cultures, preclinical animal models—particularly specialized rodent strains—are critical for evaluating systemic melanocortin responses. Mouse models with functional MC1R signaling pathways allow investigators to measure changes in follicular and cutaneous melanin content following controlled peptide administration.
In rodent assays, researchers analyze the ratio of eumelanin (brown/black photoprotective pigment) to pheomelanin (red/yellow photo-reactive pigment) synthesized by epidermal melanocytes. Preclinical studies suggest that sustained MC1R activation by Melanotan 1 shifts the biosynthetic pathway heavily toward eumelanin production. Laboratory endpoints typically include spectrophotometric skin reflectance measurements, histological sectioning of epidermal layers, and quantitative HPLC assay of extracted melanin polymers.
To contextualize Melanotan 1 within the broader landscape of melanocortin receptor agonists, laboratory researchers frequently perform head-to-head comparative assays against structurally related analogs. The melanocortin family encompasses several key compounds that differ markedly in sequence length, cyclization, and receptor subtype selectivity.
While Melanotan 1 remains a linear 13-amino-acid peptide designed primarily to target MC1R for pigmentation research, Melanotan 2 is a truncated, cyclic lactam analog that exhibits significantly broader central nervous system activity via enhanced permeability across the blood-brain barrier and higher affinity for MC3R and MC4R. Similarly, Bremelanotide (PT-141), a metabolite derivative of Melanotan 2, is primarily investigated for central neuro-receptor binding rather than peripheral cutaneous pigmentation. Comparing these peptides alongside native alpha-MSH allows researchers in the PX1 research library to evaluate how minor structural variations alter receptor subtype binding profiles and downstream physiological pathways.
Beyond direct pigment synthesis, researchers explore what Melanotan 1 is used for regarding cellular resistance to ultraviolet radiation (UVR). In vitro experiments using cultured keratinocytes and melanocytes exposed to UV light investigate whether MC1R signaling pathways contribute to genomic stability.
Preclinical evidence indicates that cAMP elevation induced by Melanotan 1 binding facilitates enhanced repair of cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts—the primary DNA lesions caused by UVB exposure. Laboratory investigators measure biomarkers such as gamma-H2AX foci, nucleotide excision repair (NER) enzyme expression, and reactive oxygen species (ROS) neutralization to assess the indirect neuroprotective and cytoprotective capacity of melanocortin signaling in skin tissue models.
To ensure experimental reproducibility across in vitro and animal models, researchers require rigorous analytical characterization of Melanotan 1 samples. High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) are the standard analytical tools used to verify chemical identity, sequence purity, and structural integrity.
Analytical specifications for research-grade peptides mandate purity thresholds typically exceeding 98.0% by HPLC area normalization. Mass spectrometry confirms the exact molecular weight (1646.85 Da) and rules out unwanted deletion sequences or incomplete synthesis side-products. Additionally, because bacterial endotoxins can confound cell culture assays by triggering non-specific inflammatory signaling pathways, lot-specific testing via Limulus Amebocyte Lysate (LAL) assays is mandatory. Laboratories buying research compounds can review batch compliance directly via verifiable Certificates of Analysis (COA).
Proper handling and preparation of lyophilized Melanotan 1 are required to maintain peptide structural stability and prevent aggregation during experimental procedures. Lyophilized vials should be stored at -20°C or -80°C in a desiccated environment prior to reconstitution.
When preparing solutions for laboratory use, sterile Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4) is typically introduced using gentle side-wall injection techniques to prevent mechanical shear stress on the peptide backbone. Researchers calculating volumetric concentrations for in vitro assays often utilize a specialized peptides reconstitution calculator to ensure precise molarity. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene tubes to avoid freeze-thaw cycles and kept at 2°C to 8°C for short-term experimentation.
Principal investigators and laboratory managers evaluating suppliers for high-throughput preclinical screening require consistent lot-to-lot purity and full supply chain transparency. Variations in peptide synthesis, residual trifluoroacetic acid (TFA) content, or moisture levels can introduce unaccounted variables into delicate cellular assays.
PX1 Research manufactures peptides in ISO 17025 accredited, GMP-compliant facilities within the USA. Each lot undergoes comprehensive third-party testing to guarantee identity, purity, and strict endotoxin compliance. Institutional researchers interested in establishing recurring supply agreements or securing high-volume reagents can explore parameters through our dedicated bulk laboratory ordering portal.
What is Melanotan 1 used for in preclinical research?
Melanotan 1 is used in laboratory settings to study melanocortin-1 receptor (MC1R) binding, intracellular cAMP signal transduction pathways, melanogenesis endpoints, and cellular photoprotective mechanisms in cultured cell lines and animal models.
How does Melanotan 1 differ from native alpha-MSH?
Melanotan 1 is a synthetic analog of alpha-MSH containing amino acid substitutions (Norleucine and D-Phenylalanine) that significantly increase its enzymatic resistance, biological half-life, and receptor binding affinity compared to the native hormone.
What melanocortin receptors does Melanotan 1 target?
Melanotan 1 is a non-selective melanocortin receptor agonist with highest affinity for MC1R, but it also demonstrates binding activity at MC3R, MC4R, and MC5R in competitive binding assays.
How is Melanotan 1 purity verified for laboratory use?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to ensure peptide purity (typically ≥98%), combined with Mass Spectrometry (MS) to confirm molecular weight and sequence identity.
Why is endotoxin testing necessary for Melanotan 1 in cell culture?
Bacterial endotoxins (lipopolysaccharides) can trigger immune responses and inflammatory pathways in cultured cells, which can artifactually alter gene expression and mask the specific effects of MC1R stimulation.
What is the recommended storage condition for lyophilized Melanotan 1?
Lyophilized Melanotan 1 powder should be stored at -20°C or -80°C in a dry, dark environment to preserve long-term chemical stability.
How does Melanotan 1 compare to Melanotan 2 in research applications?
Melanotan 1 is a linear peptide primarily studied for peripheral MC1R activity and cutaneous pigmentation pathways, whereas Melanotan 2 is a cyclic analog with higher blood-brain barrier permeability studied for central MC3R/MC4R pathways.
Can Melanotan 1 be used in human or veterinary applications?
No. Melanotan 1 supplied by PX1 Research is strictly designated for laboratory research use only by qualified scientific personnel in vitro or in preclinical animal models, and is not for human or veterinary use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.